ALLISON WHEELER: Open Payments
NPI 1639955412 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,175 in 100 payments from 17 companies in 2025. Trend: 2023 $337 · 2024 $1,094 · 2025 $2,175
Food & beverage: $1,963Education: $212
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $630 |
| Galderma Laboratories, L.P. | 24 | $511 |
| UCB, Inc. | 15 | $268 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $169 |
| ABBVIE INC. | 5 | $101 |
| GENZYME CORPORATION | 3 | $80 |
| Lilly USA, LLC | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $70 |
| Incyte Corporation | 2 | $55 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, Winlevi, DUPIXENT, EBGLYSS, COSENTYX, Sotyktu.
Industry payments across MI — which companies pay providers there.
